Nitroglycerin Infusion Rate Calculator

Q: When is nitroglycerin contraindicated in ACS?

Avoid nitroglycerin with hypotension (commonly SBP < 90 mmHg or a drop of at least 30 mmHg from baseline), suspected right ventricular or inferior MI until adequate preload is confirmed, severe aortic stenosis, and recent PDE-5 inhibitor use: avanafil within 12 hours, sildenafil or vardenafil within 24 hours, and tadalafil within 48 hours.

Q: Why can't I give nitroglycerin after a patient has taken sildenafil (Viagra)?

Both nitroglycerin and PDE-5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) act through the nitric oxide pathway. Their combined effect can cause severe, synergistic, refractory hypotension and shock. If the timing of recent use is uncertain, nitroglycerin should be withheld.

Q: What kind of IV tubing should be used for a nitroglycerin drip?

Nitroglycerin is absorbed into standard PVC tubing, reducing the delivered dose, so non-PVC (e.g., polyethylene or glass) infusion sets are recommended. If standard tubing is used, a higher titrated rate may be needed for the same clinical effect.

ⓘ Nitroglycerin infusion for ACS is not weight-based.

Select Nitroglycerin IV Preparation

Concentration: -- mcg/mL

Dose (mcg/min)	Rate (mL/hr)
Select a preparation to generate the titration table.

Show calculation steps

Recent Updates

Sources updated to the 2025 ACC/AHA and 2023 ESC acute coronary syndrome guidelines.
Clarified that IV nitroglycerin provides symptom relief only (no mortality benefit), refined PDE-5-inhibitor washout intervals, and added severe aortic stenosis and nitrate tolerance.

Source: Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation 2025. PMID: 40014670.

Key Knowledge Points

This Nitroglycerin Infusion Rate Calculator is for ACS management, targeting ongoing ischemic chest pain, uncontrolled hypertension, or signs of heart failure. IV nitroglycerin provides symptom relief only and has no proven mortality benefit (GISSI-3, ISIS-4); it does not replace reperfusion, antiplatelet, or anticoagulant therapy.
Dosing Protocol: Start at 5–10 mcg/min and titrate up by 5–10 mcg/min every 3–5 minutes until symptoms resolve or side effects occur.
Titration Endpoints: Limited by symptom relief, hypotension (SBP < 90 mmHg or a drop >30 mmHg from baseline), or significant heart rate changes. Most patients respond at ≤200 mcg/min; if uncontrolled near the ceiling, reassess the diagnosis (RV MI, dissection), volume status, and tolerance rather than escalating indefinitely.
CRITICAL Contraindications: Do NOT give with hypotension, suspected right ventricular or inferior MI (until adequate preload confirmed), severe aortic stenosis, or recent PDE-5 inhibitor use — avanafil within 12 h, sildenafil/vardenafil within 24 h, tadalafil within 48 h (withhold if timing is uncertain).
Tolerance & effects: Tachyphylaxis (nitrate tolerance) develops within ~24–48 h of continuous infusion; rising rate requirements may reflect tolerance rather than worsening ischemia. Expect headache and reflex tachycardia; methemoglobinemia is rare at very high or prolonged doses.

About This Nitroglycerin Infusion Rate Calculator

This Nitroglycerin Infusion Rate Calculator is designed as a quick bedside reference for clinicians managing patients with Acute Coronary Syndrome (ACS). It instantly generates a titration table, converting the desired dose in mcg/min to a volumetric infusion rate in mL/hr based on the selected IV bag concentration. This tool helps ensure accurate and efficient dose adjustments during the critical initial phase of ACS treatment.

The Formula Explained

The calculation to convert a dose in mcg/min to a rate in mL/hr is based on the concentration of the prepared solution.

$$ \text{Rate (mL/hr)} = \frac{\text{Dose (mcg/min)} \times 60 \text{ min/hr}}{\text{Concentration (mcg/mL)}} $$

Clinical Interpretation & Limitations

The goal of nitroglycerin therapy in ACS is to alleviate ischemia by reducing myocardial oxygen demand (via decreased preload and afterload) and increasing myocardial oxygen supply (via coronary vasodilation). It relieves symptoms but does not reduce mortality.

Starting Dose: Begin at 5–10 mcg/min.
Titration: Increase by 5–10 mcg/min every 3–5 minutes. There is no absolute maximum dose; titrate to clinical effect or dose-limiting side effects (primarily hypotension). Most patients respond at ≤200 mcg/min — if not, reassess for RV infarction, aortic dissection, hypovolemia, or tolerance.
Tolerance: Nitrate tachyphylaxis develops within ~24–48 hours of continuous infusion. Nitrate-free intervals are generally not feasible in active ACS, so favor transition to definitive therapy.
Tubing: Nitroglycerin is absorbed by standard PVC tubing. Special non-PVC tubing should be used to ensure accurate dose delivery; with standard tubing a higher titrated rate may be required.

Limitations

This tool is an aid, not a substitute for continuous patient monitoring and clinical judgment. The provided rates are mathematically correct, but the patient's hemodynamic response must be the ultimate guide for titration. This Nitroglycerin Infusion Rate Calculator is intended for the ACS protocol only; hypertensive-emergency or heart-failure protocols may differ.

Frequently Asked Questions (FAQ)

1. Why is nitroglycerin dosing not weight-based?
The therapeutic effect of nitroglycerin is systemic vasodilation, which is titrated to the patient's hemodynamic response (blood pressure, heart rate, and chest pain relief), not body mass. A fixed-dose titration protocol is therefore used.

2. Does IV nitroglycerin reduce mortality in ACS?
No. IV nitroglycerin in ACS is for symptom control — ongoing ischemic chest pain, hypertension, and pulmonary congestion/heart failure. Large trials (GISSI-3, ISIS-4) showed no mortality benefit. It does not replace reperfusion, antiplatelet, or anticoagulant therapy.

3. When is nitroglycerin contraindicated in ACS?
Avoid it with hypotension (commonly SBP < 90 mmHg or a drop of ≥30 mmHg from baseline), suspected right ventricular or inferior MI until adequate preload is confirmed, severe aortic stenosis, and recent PDE-5 inhibitor use: avanafil within 12 hours, sildenafil or vardenafil within 24 hours, tadalafil within 48 hours.

4. Why can't I give nitroglycerin after a patient has taken sildenafil (Viagra®)?
Both nitroglycerin and PDE-5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) act through the nitric oxide pathway. Their combined effect can cause severe, synergistic, refractory hypotension and shock. If the timing of recent use is uncertain, nitroglycerin should be withheld.

5. What kind of IV tubing should be used for a nitroglycerin drip?
Because nitroglycerin is absorbed into standard PVC tubing, reducing the delivered dose, non-PVC (e.g., polyethylene) infusion sets are recommended. With standard tubing, a higher titrated rate may be required to achieve the desired effect.

Related Calculators

📖 Sources:

⚠️ Disclaimer:

This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient's full clinical context.